Commentary on "Potential risk factors for Varicella-zoster virus reactivation after COVID-19 vaccination".

Turkmen, Dursun; Altunisik, Nihal; Altunisik Toplu, Sibel

Turkmen, Dursun; Altunisik, Nihal; Altunisik Toplu, Sibel.

Turkmen D; Department of Dermatology, Inonu University, Malatya, Turkey.
Altunisik N; Department of Dermatology, Inonu University, Malatya, Turkey.
Altunisik Toplu S; Department of Infectious Diseases and Clinical Microbiology, Inonu University, Malatya, Turkey.

J Cosmet Dermatol ; 21(8): 3627-3628, 2022 08.

Article in English | MEDLINE | ID: covidwho-1779253

Subject(s)

COVID-19 Vaccines; COVID-19; Herpesvirus 3, Human; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Humans; Risk Factors; Vaccination/adverse effects; Varicella Zoster Virus Infection

Keywords

herpes zoster reactivation; inactivated SARS-CoV-2 vaccine; varicella-zoster virus

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Herpesvirus 3, Human / COVID-19 Vaccines / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: J Cosmet Dermatol Journal subject: Dermatology Year: 2022 Document Type: Article Affiliation country: Jocd.14976

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google